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Commentary on ‘Simvastatin Decreases Free Radicals Formation
in the Human Abdominal Aortic Aneurysm Wall via NF-kB’
M. Vega de Céniga*
Department of Angiology and Vascular Surgery, Hospital de Galdakao-Usansolo, Barrio Labeaga s/n, 48960 Galdakao, Bizkaia, SpainThe complex biological processes associated with abdominal
aortic aneurysm (AAA) include oxidative stress and proteolysis in
relation toboth leukocyte recruitment andplatelet activation, leading
to immuno-inﬂammatory response, cell death and extracellular
matrix breakdown. A key player in regulating immune-inﬂammatory
processes is nuclear factor-kB (NF-kB), a redox-sensitive transcription
factor involved in the transmission of various signals from the cyto-
plasm to the nucleus of numerous cell types, activating genes which
codify products such as adhesion molecules, chemoattractants,
proinﬂammatory enzymes and procoagulant proteins. Piechota’s
paper conﬁrms that NF-kB could be involved in the pathogenesis of
AAA, as suggested by previous data.1
Statins have proved the greatest impact on cardiovascular
disease since aspirin. Their pleiotropic effects beyond lipid
lowering are still being researched. Recent ﬁndings suggest that the
clinical beneﬁt of these drugs could be related to a reduction in
oxidative stress, blood thrombogenicity and to anti-inﬂammatory
and immunomodulatory properties. Piechota et al offer new
interesting data on the effect of simvastatin on inﬂammation and
free radicals generation within the aortic wall. The current results
are somewhat bafﬂing, as the authors have obtained an increase in
catalase activity, and a decrease in TNFa concentration and NF-kB
expression in the AAA wall samples treated with simvastatin, but
not superoxide dismutase (SOD) activity or H2O2. This is not the
ﬁrst study to show a signiﬁcant inhibition of statins on both NF-kB
activity2 and oxidant enzymes such as NADPH oxidase and mye-
loperoxidase,3 as well as an up-regulation of the activity of anti-DOI of original article: 10.1016/j.ejvs.2012.04.020.
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doi:10.1016/j.ejvs.2012.04.030oxidant enzymes such as catalase.4 However, none have obtained
an absolute reduction in the tissue’s oxidative end-products, such
as H2O2. These are indeed difﬁcult to quantify and often the net
effect must be extrapolated indirectly, through the evaluation of
the activity of oxidant or antioxidant enzymes. Still, the exact
mechanism remains unclear.
The reduction in the incidence of cardiovascular events and
death associated with statins has been sufﬁciently proved and
current guidelines recommend that all vascular patients, unless
speciﬁcally contraindicated, should receive the drug. But the
evidence of its impact on AAA growth and rupture risk is still weak,
level B and C at best, with contradictory published results. Studies
aiming to better understand the therapeutical effects of statins are
timely and welcome.References
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